Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Strattera (atomoxetine) Treatment Report
What is Strattera?

Strattera® is a brand name for the drug atomoxetine HCL, a selective norepinephrine reuptake inhibitor used in the treatment of attention deficit hyperactivity disorder (ADHD).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 1 0
disease-related symptoms 1 0
Depression 1 0

Mouse over the table for more information

Dosages

  80 mg daily
  1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Strattera (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 100% Side effects too severe: 100%
Doctor's advice
1 50% Doctor's advice: 50%

See all 2 patients who’ve stopped taking Strattera

Duration See details about how long patients take this treatment ▼

Stopped Taking Strattera

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
1
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.